H-ras oncogene mutation in dedifferentiated chondrosarcoma: Polymerase chain reaction-restriction fragment length polymorphism analysis

Modern Pathology

Volumn 14, Issue 4, 2001, Pages 343-349

  Sakamoto, Akio ^a   Oda, Yoshinao ^a   Adachi, Toshisada ^a   Oshiro, Yumi ^b   Tamiya, Sadafumi ^a   Tanaka, Kazuhiro ^a   Matsuda, Shuichi ^a   Iwamoto, Yukihide ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b MATSUYAMA RED CROSS HOSPITAL   (Japan)

Author keywords

Conventional chondrosarcoma; Dedifferentiated chondrosarcoma; H ras mutation

Indexed keywords

ADULT; AGED; ARTICLE; CHONDROSARCOMA; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHONDROSARCOMA; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROGNOSIS; SEQUENCE ANALYSIS, DNA; SURVIVAL RATE;

EID: 0035049366     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880313     Document Type: Article

References (38)

1. Dedifferentiation of low-grade chondrosarcomas
2. Dedifferentiated chondrosarcomas
3. Central low-grade osteosarcoma with foci of dedifferentiation
4. Dedifferentiated parosteal osteosarcoma
5. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases
6. Primary malignant giant cell tumor of bone: "dedifferentiated" giant cell tumor
7. Ras genes
8. Ras oncogenes in human cancer: A review
9. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours
10. H-ras-1 point mutations in soft tissue sarcomas
11. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas
12. H-ras and K-ras gene mutations in primary human soft tissue sarcoma: Concomitant mutations of the ras gene
13. H-ras and K-ras mutations in soft tissue sarcoma: Comparative studies of sarcomas from Korean and American patients
14. Oncogene alterations in primary, recurrent, and metastatic human bone tumors
15. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma
16. Prognostic factors in chondrosarcoma of bone: A clinicopathologic analysis with emphasis on histologic grading
17. Ras oncogene mutations in thyroid tumors: Polymerase chain reaction-restriction-fragment-length polymorphism analysis from paraffin-embedded tissues
18. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors
19. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas
20. Cytogenetic analysis of dedifferentiated chondrosarcoma
21. Altered p53 is associated with aggressive behavior of chondrosarcoma: A long term follow-up study
22. p53 mutations in chondrosarcoma
23. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma
24. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas
25. Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 bands involved in primary cancer-specific rearrangements
26. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis
27. The human Ha-ras oncogene induces genomic instability in murine fibroblasts within one cell cycle
28. An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites
29. Aberrant regulation of ras proteins in malignant tumour cells from type neurofibromatosis patients
30. Ran/TC4: A small nuclear GTP-binding protein that regulates DNA synthesis
31. p53 expression in dedifferentiated chondrosarcoma
32. Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma
33. Expression of membrane type 1-matrix metalloproteinase, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma
34. Simultaneous interphase cytogenetic analysis and fluorescence immunophenotyping of dedifferentiated chondrosarcoma. Implications for histopathogenesis
35. Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases
36. Chondrosarcoma of bone with "dedifferentiation"
37. Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). II. An immunohistochemical and electron microscopic study